Key statistics
As of last trade, X T L Biopharmaceuticals Ltd (XTLB:NAQ) traded at 0.76, 43.37% above the 52 week low of 0.5301 set on Jan 02, 2026.
52-week range
| Open | 0.68 |
|---|---|
| High | 0.77 |
| Low | 0.6617 |
| Bid | 0.68 |
| Offer | 0.76 |
| Previous close | 0.7107 |
| Average volume | 27.54k |
|---|---|
| Shares outstanding | 9.46m |
| Free float | 9.37m |
| P/E (TTM) | -- |
| Market cap | 6.79m USD |
| EPS (TTM) | -0.73 USD |
Data delayed at least 15 minutes, as of Mar 06 2026 19:41 GMT.
More ▼
- XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
- XTL Update on Recent Developments
- XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
- XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
- XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- XTL Names Mr. Noam Band as its New Chief Executive Officer
More ▼
